Back to Resource Center

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction

The Market Access Framework for MPT Development and Introduction is intended to serve as a resource to inform product
development and investment decision-making that is focused specifically on market access components of MPT development and introduction—in other words, activities that are critical to ensuring that MPTs in development are not only efficacious in clinical trials, but also desired, acceptable, and accessible to women and adolescent girls once introduced and commercially available.

This framework document was prepared by Laura Dellplain (IMPT), Bethany Young Holt (IMPT), Anke Hemmerling (UCSF and IMPT Scientific Advisor), Joseph Romano (NWJ Group and IMPT Scientific Advisor), Ariane van der Straten (RTI International and IMPT Scientific Advisor), and Jim Turpin (NIAID). This work could not have been completed without the valuable insights and contributions from IMPT partner organization representatives. The IMPT Secretariat would like to thank Amy Lin and Janine Hum (USAID) in particular for their guidance and engagement during this process.

April 2019

Click to view Technical Brief

Click for full info +

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion
April 2019
In this Technical Brief:
Health Risk(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy
Product Type(s):

  • MPTs
Topic(s):

  • MPTs
  • Product Development
  • Product Trials

Full Info:


Resource Type:

Technical Brief

Citation:

Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J.  (2016, January 21). Initiative for Multipurpose Prevention Technologies.

Authors:

Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J. 

Health Risks(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy

Product type(s):

  • MPTs

Topic(s):

  • MPTs
  • Development
  • Trials
  • Social

URL of resource:

https://theimpt.org/wp/wp-content/uploads/2022/01/Market-Access-Framework-for-MPT-Development.pdf

Back to Resource Center